ArticleCureus2026
Determining Barriers to Submitting Antimicrobial-Resistant Isolates to the Texas Department of State Health Services (DSHS) Antimicrobial Resistance Laboratory Network (AR Lab Network): A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Antimicrobial Resistance Laboratory Network (AR Lab Network) was developed by the Centers for Disease Control and Prevention (CDC) to detect and prevent antimicrobial-resistant threats. However, low submission rates of antimicrobial-resistant isolates limit the AR Lab Network's ability to address antimicrobial resistance (AMR). This study expands on a study conducted in Texas Public Health Region 8 (PHR8).
aimThe aim of this study was to investigate submission barriers for antimicrobial-resistant isolates in Texas acute care hospitals (ACH) and critical access hospitals (CAH).
methodsA survey was designed and emailed to laboratory professionals to identify barriers to antimicrobial-resistant isolate submission. Responses were analyzed using two-sided Fisher's exact tests to identify associations between responses and respondent characteristics.
resultsOf the Texas laboratory personnel invited to participate, 123 responses from 211 hospitals were received, for a response rate of 58.29%. Lack of awareness of the AR Lab Network was the most frequently cited submission barrier (50.48% of respondents). Other submission barriers included submission to another laboratory (49.53%), lack of staff time (42.86%), lack of training or certified personnel (41.9%), and a submission process that was too time-consuming (40%). DISCUSSION: As in the Texas PHR8 study, it was found that, regardless of the respondent's role, time in that role, or the type of hospital in which they worked, the most common barrier to antimicrobial-resistant isolate submission was lack of awareness of the AR Lab Network. In the future, the identified barriers will be addressed by implementing educational outreach programs about the AR Lab Network for Texas hospitals and healthcare facilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.